Research progress on metabonomics of traditional Chinese medicine in the treatment of ulcerative colitis

BAI Lin; WANG Yangyang; BAI Jingyi; WEN Xinli

doi:10.6039/j.issn.1001-0408.2023.22.22

您当前的位置：

首页 >

文章列表页 >

Research progress on metabonomics of traditional Chinese medicine in the treatment of ulcerative colitis

更新时间：2023-11-25

- Research progress on metabonomics of traditional Chinese medicine in the treatment of ulcerative colitis
- ZHONGGUO YAOFANG Vol. 34, Issue 22, Pages: 2810-2816(2023)
- 作者机构：
  
  1.陕西中医药大学第一临床医学院中医系，陕西咸阳　712046
  2.陕西省中医医院脾胃病二科，西安　710003
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.22.22
  CLC： R285
- Published：30 November 2023，
  
  Received：29 April 2023，
  
  Revised：25 October 2023，
扫描看全文
白琳,王洋洋,白静怡等.中药治疗溃疡性结肠炎的代谢组学研究进展 ^Δ[J].中国药房,2023,34(22):2810-2816.

BAI Lin,WANG Yangyang,BAI Jingyi,et al.Research progress on metabonomics of traditional Chinese medicine in the treatment of ulcerative colitis[J].ZHONGGUO YAOFANG,2023,34(22):2810-2816.
白琳,王洋洋,白静怡等.中药治疗溃疡性结肠炎的代谢组学研究进展 ^Δ[J].中国药房,2023,34(22):2810-2816. DOI： 10.6039/j.issn.1001-0408.2023.22.22.

BAI Lin,WANG Yangyang,BAI Jingyi,et al.Research progress on metabonomics of traditional Chinese medicine in the treatment of ulcerative colitis[J].ZHONGGUO YAOFANG,2023,34(22):2810-2816. DOI： 10.6039/j.issn.1001-0408.2023.22.22.

摘要

溃疡性结肠炎（UC）作为临床消化系统的常见病、难治病，一直是医学研究的热点和难点。中医药在治疗UC方面具有疗效显著、安全性高、停药后不易反复等优势，但作用机制尚未完全阐明。代谢组学从整个机体内源性动态代谢角度出发，寻找潜在的生物标志物及代谢途径，有助于评价药物治疗效果和探索相关作用机制。中药治疗UC的代谢组学研究显示，中药复方、单味中药以及中药单体可通过调控机体内源性代谢物，作用于氨基酸代谢、脂质代谢、能量代谢等诸多相关通路，从而抑制免疫炎症反应、改善氧化应激、降低肠道敏感性、调节肠道菌群、修复肠道黏膜损伤，使机体恢复正常的代谢活动。但相关代谢标志物还需进一步筛选与验证。

Abstract

OBJECTIVE

Ulcerative colitis （UC）， as a common and refractory disease of the digestive system， has always been a hot and difficult point in medical research. Traditional Chinese medicine has the advantages of good efficacy， high safety and not easy to relapse after drug withdrawal in the treatment of UC， but the mechanism has not been fully elucidated. Metabonomics looks for potential biomarkers and metabolic pathways from the point of view of the endogenous dynamic metabolism of the whole body， which is helpful to evaluate the efficacy of drugs and explore related mechanisms. Metabolomics studies on the treatment of UC with traditional Chinese medicine have shown that traditional Chinese medicine formulas， single herbs and herbs monomers act on various related pathways such as amino acid metabolism， lipid metabolism and energy metabolism by regulating endogenous metabolites in the body， thereby inhibiting immune inflammatory reactions， improving oxidative stress， reducing intestinal sensitivity， regulating intestinal microbiota， repairing intestinal mucosal damage， and restoring normal metabolic activity in the body. However， further screening and validation of relevant metabolic markers are needed.

关键词

中药溃疡性结肠炎代谢组学代谢物代谢途径

Keywords

ulcerative colitismetabonomicsmetabolitemetabolic pathway

references

ANANTHAKRISHNAN A N. Epidemiology and risk factors for IBD[J]. Nat Rev Gastroenterol Hepatol，2015，12（4）：205-217.

UNGARO R，MEHANDRU S，ALLEN P B，et al. Ulcera-tive colitis[J]. Lancet，2017，389（10080）：1756-1770.

NG S C，SHI H Y，HAMIDI N，et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century：a systematic review of population-based studies[J]. Lancet，2017，390（10114）：2769-2778.

DU L，HA C. Epidemiology and pathogenesis of ulcera-tive colitis[J]. Gastroenterol Clin North Am，2020，49（4）：643-654.

RAMOS G P，PAPADAKIS K A. Mechanisms of disease：inflammatory bowel diseases[J]. Mayo Clin Proc，2019，94（1）：155-165.

王春霞，葛俊李，李芳，等. 中药治疗溃疡性结肠炎作用及机制研究进展[J]. 中国实验方剂学杂志，2023，29（2）：270-282.

WANG C X，GE J L，LI F，et al. Effect and mechanism of traditional Chinese medicine in treatment of ulcerative colitis：a review[J]. Chin J Exp Tradit Med Formulae，2023，29（2）：270-282.

艾永建，何梦崎，王一涛，等. 经典方药治疗溃疡性结肠炎的研究进展[J]. 中国中药杂志，2022，47（21）：5797-5805.

AI Y J，HE M Q，WANG Y T，et al. Review of classical prescriptions in treatment of ulcerative colitis[J]. China J Chin Mater Med，2022，47（21）：5797-5805.

周琼阁，王凯，席作武，等. 基于肠道微环境探讨中医药防治溃疡性结肠炎的机制[J]. 中国实验方剂学杂志，2023，29（7）：222-229.

ZHOU Q G，WANG K，XI Z W，et al. Mechanism of traditional Chinese medicine in prevention and treatment of ulcerative colitis：based on intestinal microenvironment[J]. Chin J Exp Tradit Med Formulae，2023，29（7）：222-229.

赵正阳，王至婉. 以代谢组学技术为代表的系统生物学技术在慢性阻塞性肺疾病研究中的运用[J]. 中华中医药学刊，2022，40（12）：23-26.

ZHAO Z Y，WANG Z W. Application of systems biology technology represented by metabonomics in COPD research[J]. Chin Arch Tradit Chin Med，2022，40（12）：23-26.

李先娜，董辉，孙晖. 代谢组学在中医药现代化研究中的应用[J]. 中医药信息，2016，33（5）：114-117.

LI X N，DONG H，SUN H. Application of metabonomics in modernization of traditional Chinese medicine[J]. Inf Tradit Chin Med，2016，33（5）：114-117.

TANG Q，CANG S，JIAO J，et al. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer：the combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer[J]. J Chromatogr A，2020，1629：461503.

COBURN L A，HORST S N，ALLAMAN M M，et al. L-arginine availability and metabolism is altered in ulcera-tive colitis[J]. Inflamm Bowel Dis，2016，22（8）：1847-1858.

耿曙光，袁代解，黄宗武，等. 基于气相色谱-质谱的大鼠溃疡性结肠炎模型结肠组织代谢组学特征[J]. 广东医学，2016，37（8）：1113-1117.

GENG S G，YUAN D J，HUANG Z W，et al. Metabolomic features of the colon tissue in ulcerative colitis rat model based on gas chromatography-mass spectrometry[J]. Guangdong Med J，2016，37（8）：1113-1117.

OOI M，NISHIUMI S，YOSHIE T，et al. GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis[J]. Inflamm Res，2011，60（9）：831-840.

KOLHO K L，PESSIA A，JAAKKOLA T，et al. Faecal and serum metabolomics in paediatric inflammatory bowel disease[J]. J Crohns Colitis，2017，11（3）：321-334.

SUN M L，DU B，SHI Y，et al. Combined signature of the fecal microbiome and plasma metabolome in patients with ulcerative colitis[J]. Med Sci Monit，2019，25：3303-3315.

方青，欧阳冬生. 氧化三甲胺与炎症性疾病[J]. 中国临床药理学与治疗学，2019，24（3）：318-326.

FANG Q，OUYANG D S. Trimethylamine N-oxide and inflammatory disease[J]. Chin J Clin Pharmacol Ther，2019，24（3）：318-326.

KESHTELI A H，VAN DEN BRAND F F，MADSEN K L，et al. Dietary and metabolomic determinants of relapse in ulcerative colitis patients：a pilot prospective cohort study[J]. World J Gastroenterol，2017，23（21）：3890-3899.

HISAMATSU T，ONO N，IMAIZUMI A，et al. Decreased plasma histidine level predicts risk of relapse in patients with ulcerative colitis in remission[J]. PLoS One，2015，10（10）：e0140716.

FRITSCH J，GARCES L，QUINTERO M A，et al. Low-fat，high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis[J]. Clin Gastroenterol Hepatol，2021，19（6）：1189-1199.e30.

DAI L，TANG Y J，ZHOU W J，et al. Gut microbiota and related metabolites were disturbed in ulcerative colitis and partly restored after mesalamine treatment[J]. Front Pharmacol，2020，11：620724.

胡楠，燕茹. 奥美拉唑在葡聚糖硫酸钠诱导的溃疡性结肠炎大鼠肝肾肠微粒体中的代谢研究[J]. 中国医院药学杂志，2017，37（8）：682-686.

HU N，YAN R. Metabolism of omeprazole in hepatic，renal and intestinal microsomes from rats with ulcerative colitis induced by dextran sulfate sodium[J]. Chin J Hosp Pharm，2017，37（8）：682-686.

王佳婕，曹云，李中峰，等. 基于核磁共振氢谱的慢性复发型溃疡性结肠炎中医虚、实证候血浆代谢组学研究[J]. 北京中医药大学学报，2018，41（9）：787-792.

WANG J J，CAO Y，LI Z F，et al. Plasma metabolomic study on deficiency or excessiveness patterns of chronic recurrent ulcerative colitis based on H-nuclear magnetic resonance[J]. J Beijing Univ Tradit Chin Med，2018，41（9）：787-792.

连紫宇，朱磊，刘亚军，等. 溃疡性结肠炎脾气虚证患者代谢特征研究[J]. 南京中医药大学学报，2021，37（6）：830-836.

LIAN Z Y，ZHU L，LIU Y J，et al. Metabolic characte-ristics of spleen-qi deficiency syndrome in ulcerative colitis[J]. J Nanjing Univ Tradit Chin Med，2021，37（6）：830-836.

王包晟，吴本升，周青，等. 基于系统生物学的溃疡性结肠炎中医证候研究现状[J]. 湖北中医药大学学报，2021，23（2）：126-129.

WANG B S，WU B S，ZHOU Q，et al. Research on TCM syndrome of ulcerative colitis based on system biology[J]. J Hubei Univ Chin Med，2021，23（2）：126-129.

刘史佳，吕翔宇，熊玥，等. 基于液质联用技术的白头翁汤治疗溃疡性结肠炎小鼠血清代谢组学分析[J]. 南京中医药大学学报，2019，35（5）：535-540.

LIU S J，LYU X Y，XIONG Y，et al. Serum metabonomics analysis of ulcerative colitis mice treated by Baitouweng decoction based on UPLC/Q-TOF-MS[J]. J Nanjing Univ Tradit Chin Med，2019，35（5）：535-540.

王敦方，王彦礼，王怡薇，等. 基于UHPLC-MS研究黄芩汤对溃疡性结肠炎大鼠血清代谢谱的影响[J]. 药学学报，2017，52（8）：1306-1312.

WANG D F，WANG Y L，WANG Y W，et al. Effect of Huangqin tang on serum metabolic profile in rats with ulcerative colitis based on UHPLC-MS[J]. Acta Pharm Sin，2017，52（8）：1306-1312.

韩丽颖，于浩，李天娇，等. 基于代谢组学的经典名方槐花散治疗溃疡性结肠炎的作用机制研究[J]. 中国中药杂志，2023，48（5）：1300-1309.

HAN L Y，YU H，LI T J，et al. Mechanism of famous classical formula Huaihua powder in treatment of ulcerative colitis based on metabonomics[J]. China J Chin Mater Med，2023，48（5）：1300-1309.

刘星赐，吴东升，曹晖，等. 基于LC-MS研究芍药汤对溃疡性结肠炎大鼠粪便代谢产物的影响[J]. 中国实验方剂学杂志，2023，29（9）：61-70.

LIU X C，WU D S，CAO H，et al. Effect of Shaoyaotang on fecal metabolites in rats with ulcerative colitis based on liquid chromatography-mass spectrometry[J]. Chin J Exp Tradit Med Formulae，2023，29（9）：61-70.

LIU M H，WANG Z H，LIU X，et al. Therapeutic effect of Yiyi fuzi baijiang formula on TNBS-induced ulcerative colitis via metabolism and Th17/Treg cell balance[J]. J Ethnopharmacol，2023，309：116301.

钟薏文，张文彤，陈雅茜，等. 基于UPLC-Q-TOF/MS和粪便代谢组学探讨参苓白术散改善脾虚湿困型溃疡性结肠炎大鼠的机制[J]. 中华中医药杂志，2023，38（2）：840-847.

ZHONG Y W，ZHANG W T，CHEN Y X，et al. Mechanism of Shenling baizhu powder on improving spleen deficiency with dampness retention-ulcerative colitis rats based on UPLC-Q-TOF/MS and fecal metabonomics[J]. China J Tradit Chin Med Pharm，2023，38（2）：840-847.

徐霞，王玮玮，张文彤，等. 基于UPLC-Q-TOF/MS的脾虚湿困型溃疡性结肠炎大鼠造模及参苓白术散给药不同阶段的血浆代谢组学分析[J]. 中国实验方剂学杂志，2022，28（15）：111-119.

XU X，WANG W W，ZHANG W T，et al. Metabolomics analysis of plasma at different stages based on UPLC-Q-TOF/MS：modeling of spleen deficiency with dampness retention-ulcerative colitis rats and administration of Shenling baizhusan[J]. Chin J Exp Tradit Med Formulae，2022，28（15）：111-119.

王婧婧，古诗琴，蔡莹，等. 参苓白术散与肾气丸干预脾肾阳虚型溃疡性结肠炎大鼠的代谢组学研究[J]. 中成药，2022，44（11）：3690-3696.

WANG J J，GU S Q，CAI Y，et al. Metabonomics study of shenlingbaizhu powder and Shenqi pill on rats with ulcera-tive colitis of spleen and kidney Yang deficiency type[J]. Chin Tradit Pat Med，2022，44（11）：3690-3696.

孙平良，耿曙光，袁代解，等. 安肠汤对溃疡性结肠炎大鼠肠黏膜组织中内源性代谢物的影响[J]. 中医杂志，2016，57（19）：1678-1683.

SUN P L，GENG S G，YUAN D J，et al. Impact of Anchang decoction on endogenous metabolites in intestinal mucosa tissue of ulcerative colitis rats[J]. J Tradit Chin Med，2016，57（19）：1678-1683.

阿依加玛力·沙依提，卡思木江·阿西木江，许晨波，等. 基于核磁共振氢谱探讨复方缓溃乐混悬剂对溃疡性结肠炎大鼠血清代谢谱的影响[J]. 中国临床药理学杂志，2020，36（23）：3910-3913.

AYIJIAMALI·SHAYITI，KASIMUJIANG·AXIMUJIANG，XU C B，et al. Effect of compound Huankuile suspension on serum metabolic profile in rats with ulcerative colitis based on 1H-nuclear magnetic resonance[J]. Chin J Clin Pharmacol，2020，36（23）：3910-3913.

胡雪黎，周昌园，徐睿，等. 基于UPLC-Q-TOF-MS技术的土家族药三颗针干预溃疡性结肠炎的代谢组学研究[J]. 中国中药杂志，2023，48（9）：2490-2499.

HU X L，ZHOU C Y，XU R，et al. Metabolomics study of Berberidis Radix in intervening ulcerative colitis based on UPLC-Q-TOF-MS[J]. China J Chin Mater Med，2023，48（9）：2490-2499.

WANG J Q，WANG X，MA X D，et al. Therapeutic effect of Patrinia villosa on TNBS-induced ulcerative colitis via metabolism，vitamin D receptor and NF-κB signaling pathways[J]. J Ethnopharmacol，2022，288：114989.

高心悦，冯美期，谢媛媛，等. 基于1H-NMR代谢组学技术研究火麻仁油干预溃疡性结肠炎的作用[J]. 中国医院药学杂志，2022，42（24）：2589-2594.

GAO X Y，FENG M Q，XIE Y Y，et al. Metabonomics study of hemp seed oil on ulcerative colitis based on 1H-NMR[J]. Chin J Hosp Pharm，2022，42（24）：2589-2594.

阿不来提·阿合买提，买提哈斯木·吾布力艾山，张景萍，等. 维药溃结安对异常黏液质溃疡性结肠炎大鼠干预效果的血清代谢组学研究[J]. 中华中医药杂志，2017，32（1）：335-340.

ABULAITI·AHEMAITI，MAITIHASIMU·WUBULIAISHAN，ZHANG J P，et al. Serum metabonomics analysis of effects of Uyghur medicine KuiJie’an on rat model of ulcerative colitis with abnormal balgam carrier[J]. China J Tradit Chin Med Pharm，2017，32（1）：335-340.

LI T，GAO X J，YAN Z X，et al. Understanding the toni-fying and the detoxifying properties of Chinese medicines from their impacts on gut microbiota and host meta-bolism：a case study with four medicinal herbs in experimental colitis rat model[J]. Chin Med，2022，17（1）：118.

朱洁，侯宝龙，程雯，等. 基于血清代谢组学探究色胺酮抗小鼠溃疡性结肠炎的作用机制[J]. 中国中药杂志，2023，48（8）：2193-2202.

ZHU J，HOU B L，CHENG W，et al. Mechanism of tryp-tanthrin in treatment of ulcerative colitis in mice based on serum metabolomics[J]. China J Chin Mater Med，2023，48（8）：2193-2202.

陈旭刚，屈树兰，陈龙. 基于LC-MS研究肉桂醛对急性溃疡性结肠炎小鼠代谢组学的影响[J]. 中药药理与临床，2021，37（1）：88-96.

CHEN X G，QU S L，CHEN L. Effect of cinnamaldehyde on metabolomics in mice with acute ulcerative colitis based on LC-MS[J]. Pharmacol Clin Chin Mater Med，2021，37（1）：88-96.

马光朝，章从恩，马致洁，等. 基于LC/IT-TOF-MS技术的雷公藤甲素干预溃疡性结肠炎的代谢组学研究[J]. 中草药，2020，51（13）：3493-3500.

MA G C，ZHANG C E，MA Z J，et al. Study on intervention of triptolide on metabolism of LC/IT-TOF-MS in ulcerative colitis[J]. Chin Tradit Herb Drugs，2020，51（13）：3493-3500.

LIAO Z Q，ZHANG S B，LIU W，et al. LC-MS-based metabolomics analysis of Berberine treatment in ulcerative colitis rats[J]. J Chromatogr B Analyt Technol Biomed Life Sci，2019，1133：121848.

MOTAVALLIAN-NAEINI A，ANDALIB S，RABBANI M，et al. Validation and optimization of experimental colitis induction in rats using 2，4，6-trinitrobenzene sulfonic acid[J]. Res Pharm Sci，2012，7（3）：159-169.

PERŠE M，CERAR A. Dextran sodium sulphate colitis mouse model：traps and tricks[J]. J Biomed Biotechnol，2012，2012：718617.

KIESLER P，FUSS I J，STROBER W. Experimental mo-dels of inflammatory bowel diseases[J]. Cell Mol Gastroenterol Hepatol，2015，1（2）：154-170.

LIU Y L，WANG X Y，HU C A A. Therapeutic potential of amino acids in inflammatory bowel disease[J]. Nu-trients，2017，9（9）：920.

PIESTANSKY J，OLESOVA D，MATUSKOVA M，et al. Amino acids in inflammatory bowel diseases：modern diagnostic tools and methodologies[J]. Adv Clin Chem，2022，107：139-213.

米宁，季之欣，武彩娥. 脂质对炎症的影响[J]. 国际病理科学与临床杂志，2012，32（5）：421-426.

MI N，JI Z X，WU C E. Effect of lipid on inflammation[J]. Int J Pathol Clin Med，2012，32（5）：421-426.

FAN F L，MUNDRA P A，FANG L，et al. Lipidomic profiling in inflammatory bowel disease：comparison between ulcerative colitis and Crohn’s disease[J]. Inflamm Bowel Dis，2015，21（7）：1511-1518.

DIAB J，HANSEN T，GOLL R，et al. Lipidomics in ulcera-tive colitis reveal alteration in mucosal lipid composition associated with the disease state[J]. Inflamm Bowel Dis，2019，25（11）：1780-1787.

张颖，付妤. 能量代谢与炎症免疫研究进展[J]. 医学研究杂志，2022，51（4）：6-9.

ZHANG Y，FU Y. Research progress of energy metabolism and inflammatory immunity[J]. J Med Res，2022，51（4）：6-9.

王曼姝，孙思彤，袁宇，等. 功能代谢组学在中药毒性评价中的研究策略及其应用[J]. 中草药，2023，54（2）：349-358.

WANG M S，SUN S T，YUAN Y，et al. Research strategy and application of functional metabolomics in toxicity evaluation of traditional Chinese medicine[J]. Chin Tradit Herb Drugs，2023，54（2）：349-358.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

UPLC-MS/MS法鉴定五味子酯甲在大鼠体内的代谢产物

Related Author

苏红宁李淳瑞王玉峰赵韶华刘敏彦

Related Institution

No data

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰